Clinical trials
Muscular Atrophy trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| University of Sao Paulo General Hospital | 3 |
| State University of Londrina | 2 |
| Escola Superior de Ciencias da Saude | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Laboratório Teuto Brasileiro S/A | 1 |
| National Institute of Cardiology, Laranjeiras, Brazil | 1 |
| Paulista University | 1 |
| Universidade Federal de Pernambuco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 17 |
| Muscular Atrophy, Spinal | 3 |
| Muscular Diseases | 3 |
| Bulbo-Spinal Atrophy, X-Linked | 2 |
| Neoplasms | 2 |
| Sarcopenia | 2 |
| Brain Injuries | 1 |
| COVID-19 | 1 |
| Cachexia | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.